Executive Compensation at the Leukemia and Lymphoma Society (2018)

The Leukemia and Lymphoma Society is a non-profit 501 (c) (3) based in Rye Brook, New York with 1,291 employees who received total compensation of $104 million, which equates to an average of $81,000 per individual. However, the IRS Form 990 (for the year ending June 30, 2018) reports that 187 individuals received more than $100,000 in compensation.

The most highly compensated individuals (12) were compensated $4.6 million (an average of $383,000 each):

• $673,287:  Louis J Degennaro, President and CEO
• $401,050:  Rosemarie A Loffredo, EVP and CFO
• $399,533:  Gwen Nichols, EVP Chief Med Officer
• $395,704:  Andrew S Coccari, EVP, Chief Prod Officer
• $372,089:  Lee M Greenberger, SVP, Chief Science Officer
• $368,709:  Claude Edkins, VP Information Tech (end 3/31/2017)
• $393,076:  Alice O’Rourke, EVP, Chief Development Officer
• $359,217:  Kathy Grisenbeck, EVP, Chief Res Officer
• $308,604:  Gordon Miller, Jr, SVP, Finance
• $297,247:  Marcie Klein, EVP, Communications
• $283,803: Elisa Weiss, SVP, Patient Access
• $282,043:  Carson Jacobi, SVP Healthcare Part

6 of the 12 most highly compensated individuals are male while 6 are female.

Severance payments of $220,000 (included above) were made to Claude Edkins.

Caitlin Proctor, daughter of a board member, received $29,239 in compensation (from 8/2017-3/2018 as an employee)

146 independent contractors received more than $100,000 in compensation with the five most highly compensated being:

• $7.6 million:  INC Research of Chicago, Illinois for clinical trial
• $6.6 million:  Patient Advocacy Foundation of Hampton, Virginia for patient assistance procedures
• $6.1 million:  Resource One of Tulsa, Oklahoma for direct marketing
• $3.9 million:  TargetCW of San Diego, California for temp staffing
• $2.9 million:  Northgate Digital Corporation of Newtown, Pennsylvania for software development

To read the IRS Form 990 (2017) for the year ending June 30, 2018, click here.